EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Indole derivatives targeting colchicine binding site as potential anticancer agents

Bharat Goel, Shivani Jaiswal iD, Shreyans K Jain

Archiv der Pharmazie · 2023

DOI: 10.1002/ardp.202300210 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, 2023. Verfasst von Bharat Goel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Colchicine, Indoles, Tubulin Modulators. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microtubules are appealing as intracellular targets for anticancer activity due to their importance in cell division. Three important binding sites are present on the tubulin protein: taxane, vinca, and colchicine binding sites (CBS). Many USFDA‐approved drugs such as paclitaxel, ixabepilone, vinblastine, and combretastatin act by altering the dynamics of the microtubules. Additionally, a large number of compounds have been synthesized by medicinal chemists around the globe that target different tubulin binding sites. Although CBS inhibitors have proved their cytotoxic potential, no CBS‐targeting drug had been able to reach the market. Several studies have reported design, synthesis, and biological evaluation of indole derivatives as potential anticancer agents. These compounds have been shown to inhibit cancer cell proliferation, induce apoptosis, and disrupt microtubule formation. Moreover, the binding affinity of these compounds to the CBS has been demonstrated using molecular docking studies and competitive binding assays. The present work has reviewed indole derivatives as potential colchicine‐binding site inhibitors. The structure–activity relationship studies have revealed the crucial pharmacophoric features required for the potent and selective binding of indole derivatives to the CBS. The development of these compounds with improved efficacy and reduced toxicity could potentially lead to the development of novel and effective cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsColchicineIndolesTubulin ModulatorsNeoplasmsHumansBinding SitesStructure-Activity RelationshipCell ProliferationMolecular Docking SimulationMolecular StructureTubulinAnimalsApoptosis

Stichwörter der Autor:innen

cancercolchicine binding siteindoletubulin

Substanzen

Antineoplastic AgentsColchicineIndolesTubulin ModulatorsTubulin

Autor:innen und Institutionen

  • Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, India.
  • Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.

ORCID-Profile: Shivani Jaiswal

Förderung

  • None

Zitieren

APA

Goel, B., Jaiswal, S., & Jain, S. K. (2023). Indole derivatives targeting colchicine binding site as potential anticancer agents. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300210

Vancouver

Goel B, Jaiswal S, Jain SK. Indole derivatives targeting colchicine binding site as potential anticancer agents. Archiv der Pharmazie. 2023. doi:10.1002/ardp.202300210

BibTeX
@article{Goel2023,
  author = {Goel, Bharat and Jaiswal, Shivani and Jain, Shreyans K},
  title = {Indole derivatives targeting colchicine binding site as potential anticancer agents},
  journal = {Archiv der Pharmazie},
  year = {2023},
  doi = {10.1002/ardp.202300210}
}
Kostenlos starten →